Get started
Enlivex Ltd.Enlivex Ltd.Enlivex Ltd.

Enlivex Ltd.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonals
Full chart
Full chart

Compare with Enlivex Ltd.



Key stats


Market capitalization
‪26.59 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
0.00
Basic EPS (TTM)
405.56 USD
Net income (FY)
‪1.24 B‬ USD
Revenue (FY)
0.00 USD
Shares float
‪3.10 M‬
Beta (1Y)
0.47

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
34
Change (1Y)
−2−5.56%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪36.34 M‬ USD

Details


Sector
Health Technology
Industry
Biotechnology
CEO
Oren Hershkovitz
Website
enlivex.com
Headquarters
Ness Ziona
Founded
2012
IPO date
Jul 30, 2014
ISIN
IL0011319527
FIGI
BBG005ZL1Z86
Identifiers
ISIN IL0011319527
CFI code
ESVUFR
Enlivex Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of ENLV is 1.58 USD — it has decreased by −6.51% in the past 24 hours. Watch Enlivex Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Enlivex Ltd. stocks are traded under the ticker ENLV.
ENLV stock has fallen by −20.20% compared to the previous week, the month change is a −73.71% fall, over the last year Enlivex Ltd. has showed a −93.38% decrease.
We've gathered analysts' opinions on Enlivex Ltd. future price: according to them, ENLV price has a max estimate of 80.00 USD and a min estimate of 80.00 USD. Watch ENLV chart and read a more detailed Enlivex Ltd. stock forecast: see what analysts think of Enlivex Ltd. and suggest that you do with its stocks.
ENLV reached its all-time high on Jul 31, 2014 with the price of 3,960.00 USD, and its all-time low was 1.53 USD and was reached on Aug 14, 2026. View more price dynamics on ENLV chart.
See other stocks reaching their highest and lowest prices.
ENLV stock is 11.76% volatile and has beta coefficient of 0.47. Track Enlivex Ltd. stock price on the chart and check out the list of the most volatile stocks — is Enlivex Ltd. there?
Today Enlivex Ltd. has the market capitalization of ‪26.59 M‬, it has decreased by −51.15% over the last week.
Yes, you can track Enlivex Ltd. financials in yearly and quarterly reports right on TradingView.
Enlivex Ltd. is going to release the next earnings report on Aug 24, 2026. Keep track of upcoming events with our Earnings Calendar.
ENLV earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.30 USD resulting in a −3.33% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about Enlivex Ltd. earnings.
Enlivex Ltd. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ENLV net income for the last quarter is ‪1.24 B‬ USD, while the quarter before that showed ‪−2.21 M‬ USD of net income which accounts for 0.00% change. Track more Enlivex Ltd. financial stats to get the full picture.
No, ENLV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 16, 2026, the company has 34 employees. See our rating of the largest employees — is Enlivex Ltd. on this list?
Like other stocks, ENLV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enlivex Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enlivex Ltd. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enlivex Ltd. stock shows the sell signal. See more of Enlivex Ltd. technicals for a more comprehensive analysis.